Skip to main content
Menu
US

ValiScreen Human Relaxin GPCR135 (RXFP3) Cell Line, CHO-K1 Cells

Stable, recombinant ValiScreen® cell line expressing the Relaxin receptor RXFP3, human recombinant in CHO-K1 host cells.

For research use only. Not for use in diagnostic procedures. Cell Line Terms and Conditions must be accepted before orders are placed. Additional agreement needed for commercial use. Click here.

Overview

Revvity's ValiScreen cell lines are provided in two vials of frozen cells, each containing ~2.5 x 106 cells. Detailed product information as well as recommended cell culture conditions and validation assay date are available each cell line.

Clonal selection Revvity's ValiScreen cell lines is carried out with receptor binding. High and low expressors are n tested and selected optimal binding and functional response according to receptor specific transduction pathway.

Revvity’s ValiScreen cell lines require accepted cell line Terms and Conditions prior to order processing. Additional agreement needed for commercial use. Please use link above to accept Terms and Conditions or to request an agreement for commercial use.

Specifications

Application
Drug Discovery & Development
Assay Validation
Binding
Assay Target Class
GPCR
Brand
ValiScreen
G-Alpha Natural Receptor
Gi/Go
Host
CHO-K1
Product Group
Cell Line
Receptor Type
Relaxin
Species
Human
Shipping Conditions
Shipped in Dry Ice
Special Ordering Information
Requires accepted Terms and Conditions. Additional agreement needed for commercial use.
Therapeutic Area
Central Nervous System
Inflammation
Metabolic
Unit Size
5 million cells

Resources

1-1 of 1 Resources
Brochure Icon
Brochure
Radioligand selection guide

Discover a comprehensive collection of GPCR cell lines, membrane preparations, and complementary radioligands designed to drive...

Scroll Icon